Variability Wide Across Practices for Definitions of At-Risk Retinoblastoma
The decision to offer adjuvant chemotherapy and radiotherapy depends on the definition of “high-risk” retinoblastoma, but this definition varies by practice.
Ophthalmic Oncology
Combo Provides Lasting Benefit in Asymptomatic Patients With Melanoma Brain Metastases
The 3-year intracranial progression-free survival rate was 54% in asymptomatic patients and 18.9% in symptomatic patients.
Caregivers of Childhood Cancer Survivors Concerned About COVID-19 Vaccines
Many caregivers of children with a history of cancer expressed COVID-19 vaccine hesitancy early in the vaccine rollout.
Injection Significantly Reduces in Choroidal Melanoma Tumor Growth
Three weekly doses of intravitreal AU-011 led to a significant reduction of tumor growth after a year of treatment.
Aqueous Humor Biomarkers May Be Diagnostic for Vitreoretinal Lymphoma
Researchers evaluate the use of the L265P mutation in the MYD88 gene as a diagnostic tool for vitreoretinal lymphoma.
Immune Checkpoint Inhibitors Linked With Extensive Adverse Ocular Events
The complications were most commonly seen in patients taking ipilimumab.
Most Optic Pathways Gliomas Managed Conservatively
Researchers show visual outcomes of patients with neurofibromatosis type 1 and optic pathways gliomas.
Depression Following Facial Mohs Micrographic Surgery Characterized
Researchers quantified rates of depressive symptoms in the short-term postoperative period using PHQ-8 scores at baseline and at follow-up intervals.
Biopsy, Not Flow Cytometry, Is Best for Diagnosing Orbital Lymphoma
Researchers reported that flow cytometry from fresh frozen biopsy tissue as a diagnostic test only rendered a positive result 55% of the time.
Pagetoid Intraepithelial Neoplasia Linked With Tumor-Related Mortality
Researchers examined clinical characteristics and prognosis of patients with pagetoid, bowenoid, or papillary intraepithelial growth patterns.
- Loading...
Loading...
Next post in General Ophthalmology
Loading... 
Loading...